Home Depot, MSG, Beyond Meat

Discover the companies that make headlines at noon:

Home Depot – Home Depot shares rose more than 4% on Tuesday after the company announced earnings per share higher than expected by analysts. The Atlanta-based retailer posted adjusted earnings per share of $ 3.17 in its latest quarter, exceeding Refinitiv's estimate of $ 3.08. The company missed revenue forecasts for the quarter and lower sales forecasts for the year, due to commercial concerns and lower lumber prices.

Beyond Meat – The shares of the factory-based hamburger company jumped 8% after an analyst at J.P. Morgan outperformed them to move from the neutral position. The analyst said that Beyond Meat has the potential to increase its customer base with its secondary stock.

Medtronic – Medtronic's stock rose more than 4% on strong quarterly results. The medical device maker made a profit of $ 1.26 per share for a business turnover of $ 7.493 billion. Analysts surveyed by Refinitiv were expecting earnings per share of $ 1.18 on a revenue of $ 7.396 billion. Medtronic sales exceeded estimates in all divisions, including cardiac and vascular devices.

Kohl's – Kohl's shares have fallen more than 5% after reporting lower than expected comparable sales for comparable stores in the second quarter. The retailer's comparable store sales dropped more than 2.9% in the second quarter. Analysts surveyed by Refinitiv were expecting a decline of 2.5%.

TJX Companies – TJX shares declined 1.4% after reporting lower than expected revenue for the second quarter. The company's revenues totaled $ 9.782 billion for the quarter, which is lower than Refinitiv's estimates of $ 9.901 billion. Same-store sales, a key measure for retailers, increased 2% in the quarter, to below 3%. The company has lower sales in all segments internationally.

Madison Square Garden – Shares of Madison Square Garden plummeted by more than 9% – en route to their worst day in history – after sports and entertainment company missed analysts' expectations regarding financial results his fourth fiscal quarter. The company recorded losses of $ 3.08 per share on a $ 263.6 million business figure. Analysts had forecast a loss of $ 2.61 per share on a turnover of $ 270.1 million, according to Refinitiv. The Company's losses increased compared to the same period last year, due in part to the increase in personnel costs and expenses related to a proposed split in its sporting activity.

Sarepta Therapeutics – The drug manufacturer's stock dropped by more than 16% after the Food and Drug Administration rejected a new drug application aimed at obtaining the rapid approval of golodirsen, a drug intended to treat Duchenne muscular dystrophy.

AbbVie – An analyst at Piper Jaffray has brought AbbVie to neutrality, citing the "immediate" increase in profits and cost savings from the acquisition of Allergan. AbbVie shares rose 0.8%.

HP Inc. – HP Inc. has been downgraded to neutral, which has highlighted the headwinds that affect its business PC business after updating Windows 10. The stock traded 1% lower.

-CNBC & # 39; s Jesse Pound and Elizabeth Myong contributed to this report.